PT Medikaloka Hermina TbkISX:HEAL +3.68%72 Net Margin % is 5.68% as of Mar. 2026, which is 13% below its 10-year median of 6.56. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,577.62 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 63.21% on this metric.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's Net Margin % or its related term are showing as below:
ISX:HEAL'
s Net Margin % Range Over the Past 10 Years
Min: 2.77 Med: 6.56 Max: 16.97
Current: 5.62
ISX:HEAL's Net Margin % is ranked better than 63.21% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs ISX:HEAL: 5.62
PT Medikaloka Hermina Tbk (ISX:HEAL) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PT Medikaloka Hermina Tbk Net Margin % Related Terms
PT Medikaloka Hermina Tbk Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Net Margin % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Net Margin % of 5.68% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 13% below median its historical median of 6.56. Over the past decade, PT Medikaloka Hermina Tbk's Net Margin % has ranged from 2.77 to 16.97. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #245 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 36.8%.
Is PT Medikaloka Hermina Tbk's Net Margin % too high?
PT Medikaloka Hermina Tbk's current Net Margin % of 5.68% is 13% below median its 10-year median of 6.56. Over the past 10 years, this metric has ranged from a low of 2.77 to a high of 16.97. The Healthcare Providers & Services industry median Net Margin % is 2.92. PT Medikaloka Hermina Tbk's value of 5.68% is 94.9% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #245 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #245 out of 666 companies for Net Margin %. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median Net Margin % is 2.92. PT Medikaloka Hermina Tbk's value of 5.68% is 94.9% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own Net Margin % has ranged from 2.77 to 16.97 over the past decade. While the company's 10-year median is 6.56 vs. the industry median of 2.92, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Net Margin % of 5.68% is 94.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Net Margin % is 5.68%, which is 13% below median its own 10-year median of 6.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,577.62, compared to a current price of Rp845.00 — trading 46.4% below its estimated fair value. The current Net Margin % is 5.68%, which is 13% below median its 10-year median of 6.56 and 94.9% above the Healthcare Providers & Services industry median of 2.92. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Net Margin % is 5.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp845.00 is trading 46.4% below its estimated GF Value™ of Rp1,577.62.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Net Margin %: 5.68% (13% below median its 10-year median of 6.56)
GF Value™: Rp1,577.62 vs. price of Rp845.00 (46.4% below fair value)
Industry Position: 94.9% above the Healthcare Providers & Services median (#245 of 666)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
